Remed Co.Ltd - Asset Resilience Ratio
Remed Co.Ltd (302550) has an Asset Resilience Ratio of 8.46% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Remed Co.Ltd total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2017–2025)
This chart shows how Remed Co.Ltd's Asset Resilience Ratio has changed over time. See 302550 total equity for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Remed Co.Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 302550 company net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩4.56 Billion | 8.46% |
| Total Liquid Assets | ₩4.56 Billion | 8.46% |
Asset Resilience Insights
- Limited Liquidity: Remed Co.Ltd maintains only 8.46% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Remed Co.Ltd Industry Peers by Asset Resilience Ratio
Compare Remed Co.Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
INKON Life Technology Co Ltd
SHE:300143 |
Medical Devices | 3.37% |
|
CareRay Digital Medical Technology Co Ltd
SHG:688607 |
Medical Devices | 16.21% |
|
Senseonics Holdings, Inc. Common Stock
NYSE MKT:SENS |
Medical Devices | 54.67% |
|
Universus Photo Imagings Limited
NSE:UNIVPHOTO |
Medical Devices | 30.97% |
|
HansBiomed Corporation
KQ:042520 |
Medical Devices | 9.13% |
|
Aligned Genetics Inc
KQ:238120 |
Medical Devices | 2.22% |
|
Heramed Ltd
AU:HMD |
Medical Devices | 0.83% |
|
Acarix A/S
ST:ACARIX |
Medical Devices | 37.81% |
Annual Asset Resilience Ratio for Remed Co.Ltd (2017–2025)
The table below shows the annual Asset Resilience Ratio data for Remed Co.Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 8.46% | ₩4.56 Billion ≈ $3.09 Million |
₩53.91 Billion ≈ $36.53 Million |
-9.62pp |
| 2024-12-31 | 18.08% | ₩10.68 Billion ≈ $7.24 Million |
₩59.06 Billion ≈ $40.03 Million |
+10.19pp |
| 2023-12-31 | 7.89% | ₩4.35 Billion ≈ $2.95 Million |
₩55.06 Billion ≈ $37.31 Million |
-31.31pp |
| 2022-12-31 | 39.20% | ₩30.63 Billion ≈ $20.76 Million |
₩78.13 Billion ≈ $52.94 Million |
-7.97pp |
| 2021-12-31 | 47.17% | ₩36.42 Billion ≈ $24.68 Million |
₩77.20 Billion ≈ $52.32 Million |
-9.50pp |
| 2020-12-31 | 56.67% | ₩41.64 Billion ≈ $28.22 Million |
₩73.47 Billion ≈ $49.79 Million |
+13.13pp |
| 2019-12-31 | 43.54% | ₩15.22 Billion ≈ $10.31 Million |
₩34.95 Billion ≈ $23.68 Million |
+14.33pp |
| 2018-12-31 | 29.21% | ₩6.28 Billion ≈ $4.26 Million |
₩21.51 Billion ≈ $14.58 Million |
+6.47pp |
| 2017-12-31 | 22.74% | ₩2.86 Billion ≈ $1.94 Million |
₩12.59 Billion ≈ $8.53 Million |
-- |
About Remed Co.Ltd
Remed Co.,Ltd. engages in the manufacture and supply of medical devices worldwide. The company offers transcranial magnetic stimulator, a technology for the treatment of disorders, such as stroke, autism, dementia, Parkinson's disease, developmental disorders, and tinnitus. It also offers neuro magnetic stimulation systems for helping blood circulation, treating pain, neurons, regenerating cells,… Read more